| 000 | 01502 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250515021029.0 | ||
| 264 | 0 | _c20060421 | |
| 008 | 200604s 0 0 eng d | ||
| 022 | _a0391-4097 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aIsidori, A M | |
| 245 | 0 | 0 |
_aAndrogens, cardiovascular disease and osteoporosis. _h[electronic resource] |
| 260 |
_bJournal of endocrinological investigation _c2005 |
||
| 300 |
_a73-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAging _xblood |
| 650 | 0 | 4 |
_aAndrogens _xblood |
| 650 | 0 | 4 |
_aAtherosclerosis _xepidemiology |
| 650 | 0 | 4 |
_aBody Composition _xdrug effects |
| 650 | 0 | 4 |
_aBone Density _xdrug effects |
| 650 | 0 | 4 |
_aBone Density Conservation Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBone and Bones _xdrug effects |
| 650 | 0 | 4 |
_aCardiovascular Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aDiphosphonates _xpharmacology |
| 650 | 0 | 4 | _aHormone Replacement Therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHydroxymethylglutaryl-CoA Reductase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aInflammation _xetiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOsteoporosis _xdrug therapy |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aTestosterone _xblood |
| 700 | 1 | _aGiannetta, E | |
| 700 | 1 | _aPozza, C | |
| 700 | 1 | _aBonifacio, V | |
| 700 | 1 | _aIsidori, A | |
| 773 | 0 |
_tJournal of endocrinological investigation _gvol. 28 _gno. 10 Suppl _gp. 73-9 |
|
| 999 |
_c16158776 _d16158776 |
||